Newsfeeds - Spark Newswire

2 minute read

I-Mab And AbbVie Entered Amendment To Original License And Collaboration Agreement; Parties Will Continue To Collaborate On Anti-CD47 Antibody Program, I-Mab Eligible to Receive Up To $1.295B Milestones

Today, 5:19 PM

I-Mab (the “Company”) (NASDAQ:IMAB) today announced that the Company and AbbVie Global Enterprises Ltd. (as assignee of AbbVie Ireland Unlimited Company) (“AbbVie”) have entered into an amendment

ABBV

7 minute read

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:19 PM

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

AEMD

6 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 5:19 PM

On Monday, 92 companies set new 52-week lows.

ABVC

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 5:19 PM

AEMD

5 minute read

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 5:19 PM

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

AEMD

2 minute read

Recap Of Friday’s Biotech Catalysts – End Of The Day Summary

By Ragothaman Srinivasan

Today, 5:19 PM

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and…

BMY

3 minute read

21 Stocks Moving in Wednesday’s Pre-Market Session: Revlon, La-Z-Boy, Houston American, Ovintiv And More

By Lisa Levin

Today, 5:19 PM

Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday.

AAU

6 minute read

83 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:19 PM

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

ACLX

1 minute read

HC Wainwright & Co. Maintains Buy on I-MAB, Lowers Price Target to $70

By Benzinga Newsdesk

Today, 5:19 PM

HC Wainwright & Co. analyst Andrew Fein maintains I-MAB (NASDAQ:IMAB) with a Buy and lowers the price target from $80 to $70.

IMAB

5 minute read

70 Biggest Movers From Friday

By Lisa Levin

Today, 5:19 PM

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.

ACB